SEC Form 4 · accession 0001371217-18-000003
ReShape Lifesciences Inc. · RSLS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott P Youngstrom
Officer — CFO and SVP, Finance
Period of report
Apr 18, 2018
Accepted (ET)
Apr 20, 2018 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001371217
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value per share | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.653 | Apr 18, 2018 | A | 1,161,797 | A | — | Apr 18, 2028 | Common stock | 1,161,797 | 1,161,797 | D |
Explanation of responses
- F1Subject to the employee's continued service, 25% of shares will vest on the one-year anniversary of April 18, 2018 and the remaining 75% of shares will vest in as nearly equal amounts as possible on the last day of each of the next 36 months thereafter.